Literature DB >> 9144745

Synthesis and beta-adrenergic activities of R-fluoronaphthyloxypropanolamine.

A Adejare1, S S Sciberras.   

Abstract

PURPOSE: Many biogenic amines where an aromatic proton is substituted with fluorine have exhibited pharmacological properties that are dependent on the position of fluorine on the aromatic ring. For example, 6-fluoroepinephrine is selective for alpha-adrenergic receptors whereas the 2-fluoroisomer is selective for beta-receptors. Aryloxypropanolamines are beta-receptor agonists or antagonists, depending on the aryl group and its substituents. We therefore hypothesized that fluorine substitution on the atomatic ring could lead to significant biological effects in this class. A target with fluorine on naphthyl group of a known beta-antagonist was chosen for investigation.
METHODS: Synthesis of the target compound began with fluoronaphthalene and involved introduction of 4-hydroxy group by Friedel-Crafts acylation followed by Baeyer Villiger oxidation. The side chain was introduced stereoselectively using the chiral synthon (2R)-glycidyl 3-nitrobenzenesulfonate, a Sharpless epoxidation technique. The epoxide was opened with t-butyl amine. HPLC methods were used to characterize %ee of the enantiomer.
RESULTS: The target compound was synthesized in several hundred milligram quantity, and in good yield and high enantiomeric excess, showing practicality of the synthetic scheme. It exhibited potent binding activities on beta-adrenergic receptors, and was found to be two times selective for beta 2-receptors over beta 1.
CONCLUSIONS: The current report demonstrates that aromatic fluorine substitution on beta-adrenergic ligands can be achieved, and that such can be used to obtain binding selectivity between beta receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144745     DOI: 10.1023/a:1012172121453

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Effect of fluorine substitution on the agonist specificity of norepinephrine.

Authors:  D Cantacuzene; K L Kirk; D H McCulloh; C R Creveling
Journal:  Science       Date:  1979-06-15       Impact factor: 47.728

2.  Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes.

Authors:  K P Minneman; L R Hegstrand; P B Molinoff
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

Review 3.  The chemistry and biology of ring-fluorinated biogenic amines.

Authors:  K L Kirk; C R Creveling
Journal:  Med Res Rev       Date:  1984 Apr-Jun       Impact factor: 12.944

4.  Effect of fluorine substitution on the adrenergic properties of 3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol.

Authors:  A Adejare; J Y Nie; D Hebel; L E Brackett; O Choi; F Gusovsky; W L Padgett; J W Daly; C R Creveling; K L Kirk
Journal:  J Med Chem       Date:  1991-03       Impact factor: 7.446

5.  Syntheses and adrenergic activities of ring-fluorinated epinephrines.

Authors:  A Adejare; F Gusovsky; W Padgett; C R Creveling; J W Daly; K L Kirk
Journal:  J Med Chem       Date:  1988-10       Impact factor: 7.446

6.  Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.

Authors:  R N Kalaria; A C Andorn; M Tabaton; P J Whitehouse; S I Harik; J R Unnerstall
Journal:  J Neurochem       Date:  1989-12       Impact factor: 5.372

7.  5-fluoro- and 8-fluorotrimetoquinol: selective beta 2-adrenoceptor agonists.

Authors:  M T Clark; A Adejare; G Shams; D R Feller; D D Miller
Journal:  J Med Chem       Date:  1987-01       Impact factor: 7.446

  7 in total
  1 in total

Review 1.  Novel NMDA receptor modulators: an update.

Authors:  Rose M Santangelo; Timothy M Acker; Sommer S Zimmerman; Brooke M Katzman; Katie L Strong; Stephen F Traynelis; Dennis C Liotta
Journal:  Expert Opin Ther Pat       Date:  2012-09-26       Impact factor: 6.674

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.